Author : AM Tris Hardyanto
1. The Golden
Thread: Quiet Promises and the Lives They Save
What if the
man who helped save millions of lives never asked for a single thank you. No
stadiums, no speeches, no cape. Just one quiet man who kept turning up, year
after year, rolling up his sleeve while the rest of the world went to work,
cooked dinner, argued over bills, tucked children into bed.
For more
than sixty years he sat in an ordinary chair, in an ordinary room, while his
blood slipped silently into plastic bags and went out to do extraordinary
things. This is the story of James Harrison, an Australian railway worker whose
golden arm helped protect an estimated 2.4 million babies from a disease that
once stole newborns before they could take their first breath.
It sounds
like something the gods might boast about in old myths. Yet James lived in a
small house, took the train, worried about needles, told bad jokes to nurses,
and went home with the same tiredness and shopping lists as anyone else. His
life looked unremarkable from the outside, until you traced the line of what
his blood kept setting in motion.
Beneath
that astonishing number lies something even more important than medicine. It is
a lesson in quiet glory, the kind that does not trend, does not shout, does not
polish itself for the camera, and yet somehow lives on in other people's lungs,
in their laughter, in the lives they go on to build. His story asks us who, in
our own lives, has carried that same invisible weight.
When you
have lived long enough, you start to notice that people like this quietly hold
the world together. Not the loudest voices, not the ones on stages, but the
ones who keep a promise long after the applause would have faded. People whose
names most of us will never know, yet whose choices live in our children's
lungs and in the steady rhythm of ordinary days.
They are
there in the morning school run, in the noisy dinner table, in the teenager
slamming a bedroom door in a house that only exists because someone, somewhere,
once decided to show up and keep saying yes. James's life is one golden thread
in this hidden fabric, and as you follow it, you may notice faint glimmers of
your own.
The
narrative of James Harrison, an Australian railway worker whose blood donations
are linked with protecting more than 2.4 million babies, offers more than a
striking statistic. It gives a human face to the quiet engine behind many
advances in immunotherapy and transfusion medicine. His story shows how one
person's decision can become part of a vast, shared immune shield.
Intravenous
immunoglobulin, or IVIG, is a plasma product made primarily from immunoglobulin
G collected from the pooled plasma of thousands of donors. Clinicians use it to
treat a wide range of autoimmune diseases and to protect vulnerable patients,
including newborns at risk of serious illness (Gillespie & Ruitenberg,
2022). In maternal fetal medicine, IVIG and related preparations stand between
fragile infants and conditions that once felt inevitable.
In
hemolytic disease of the newborn, maternal antibodies can strip red cells from
an infant's circulation, leaving pallor, heart strain, and in severe cases,
death. The success of IVIG and related immunoglobulin approaches in treating
and preventing such conditions rests on a simple, quiet fact. Somewhere, donors
like Harrison sat in chairs, let the needle in, and allowed their antibodies to
flow into a shared pool (Triolo et al., 2004).
Maheshwari
and colleagues show that many plasma donors do not use heroic language to
describe their decision. They describe a desire to help, to give back, to feel
part of something that lifts others. In their study, altruism motivated up to
99.5 percent of donors, who saw their plasma as a way to touch lives they would
never meet (Maheshwari et al., 2022). The science runs on numbers; the donors
run on memory and feeling.
Patients
who receive IVIG rarely know the faces behind their treatment. Yet for those
living with an immune deficiency or autoimmune disease, each infusion is a
quiet bridge built from many arms. For infants with congenital infections or
other severe conditions, pooled IgG has become the standard of care in modern
paediatrics (Ben Nathan et al., 2009; Triolo et al., 2004). Behind every drip
stand lies a small crowd of unseen helpers.
The
effectiveness of these therapies depends on a steady flow of plasma from people
who keep turning up. Each unit contributes to a shared reservoir that can
stabilise infections, dampen autoimmune storms, and support recovery in fragile
patients (Montoliu Gaya & Villegas, 2016; Gharebaghi et al., 2020). One bag
does not change the world, yet over time, the pattern emerges, like stitches
building a quilt.
Demand for
plasma-derived products continues to increase worldwide. Clinicians now rely on
IVIG for an expanding list of indications, from neonatal medicine to chronic
autoimmune disorders (Xiao et al., 2020). This rising need exposes a quiet
vulnerability. Health systems look stable on paper, yet they lean heavily on
the repeated kindness of individuals whose names rarely appear in headlines.
Harrison's
long journey, and the ethos it represents, remind us that the fabric of
healthcare is not built solely from guidelines and devices. It is woven from
countless selfless acts that rarely appear in statistics, yet hold hospital
corridors together (Rajan & Narayanan, 2023; Triolo et al., 2004). His
story invites each reader to see the pattern more clearly and to ask where
their own thread might be tied.
2. The Day the
World Almost Lost Him
Picture a
fourteen-year-old boy in a small Australian hospital in 1951. The air smells of
antiseptic and metal. The lights glare down, too bright for tired eyes. His
chest has been opened to repair a damaged lung; two-thirds of it has been
removed. Bags of donated blood swing gently on their hooks until the numbers
stop meaning anything.
James
drifts in and out of consciousness. Sometimes there is nothing but a soft white
fog. Sometimes he feels a cool river slipping into his arm, followed by a heavy
tide in his chest. Voices hover above him like distant thunder. Someone says, "Without
the transfusions, he would not have made it." The words float past him,
then settle somewhere deep.
For three
months, he lies in that bed, stitched together by surgeons and by the kindness
of strangers he will never meet. Outside, trains run, factories hum, and the
world keeps its usual rhythm. Inside, his body slowly relearns how to be alive.
The days blur, yet one afternoon lands with unusual clarity, like a stone
breaking the surface of a pond.
A nurse
explains it plainly. "You lost much blood, love. Donors kept you here.
People who came in and gave, just in case someone needed it. You were that
someone." The words carry a quiet weight. His heartbeat carries the
fingerprints of strangers. He does not know the word Ubuntu, I am because we
are, yet he has just breathed it.
His life no
longer feels like it belongs to him alone. It has been patched and strengthened
by hands he will never shake. In that fragile in-between space, he makes a
promise no one else hears. When I am old enough, I will give blood back. No
contract. No audience. Just a whispered vow between a boy and the universe that
almost let him go.
Years
later, when I think of James, I think of the promises many of us once made in
hospital corridors and quiet midnights. Promises born out of fear and relief.
Some fade as life moves on. Some return in small, stubborn ways that no one
else notices, yet quietly change the shape of a life and the pattern of other
lives around it.
The image
of a fourteen-year-old boy, pale under harsh hospital lights in 1951, captures
the intimate power of transfusion medicine. James Harrison's survival depended
on donated blood that he would never be able to repay the people who supplied
it. His experience and his silent vow echo a larger truth about how health
systems lean on unseen generosity (Wang et al., 2004).
Blood
transfusions sit at the heart of modern hospital care. Clinicians rely on them
during trauma, major surgery, obstetric emergencies, and complex medical
conditions. For patients like James, whose damaged lung required extensive
surgery, transfused blood is not an optional extra. It becomes the thin red
line between a life that ends in adolescence and a life that has time to unfold
(Wang et al., 2004).
Ethical and
medical frameworks describe blood donation in measured language, yet the
motivation often begins in a simple desire to help. Many donors report giving
blood because they want their community to be safer, because they remember a
story like James's, or because they themselves once needed help (Gahan et al.,
2021). Underneath guidelines and eligibility criteria lies something deeply
human.
James's
unspoken promise to donate when he grew older fits closely with the idea
captured in the word Ubuntu: "I am because we are." Gahan and
colleagues note that donors often see themselves as part of a living network in
which one person's health depends on another's willingness to give (Gahan et
al., 2021). His story makes this philosophy visible and specific.
Studies on
blood donation show how personal experiences of illness or near loss can
transform into a drive to help others. People who have stood at the edge of
life often describe a heightened sensitivity to others' vulnerability, and this
sensitivity can become a powerful source of prosocial behaviour (Akhtar et al.,
2017; Gupta et al., 2013). The wound and the rescue are rarely the end of the
story.
Blood
services face constant challenges in recruiting and retaining donors.
Organisations such as the Australian Red Cross continually work to ensure
adequate supplies, especially as populations age and medical needs grow (Cable
et al., 2007). Narratives like James's help bridge the gap between abstract
appeals and lived experience. They show what donated blood actually looks like
in a human life.
At the same
time, transfusion medicine carries risks that require careful management.
Safety protocols for screening, cross-matching, and monitoring exist to protect
both donors and recipients from complications, including transfusion reactions
and infections (Eder et al., 2007). Vasudev and colleagues emphasise the value
of honest education, so that potential donors feel reassured by the evidence
rather than driven only by fear or guilt (Vasudev et al., 2016).
James's
promise, formed in the haze of recovery, became a quiet response to this whole
system of care. He moved from being the rescued child to the adult who chose to
step into the same chain from the other side. His journey mirrors a broader
pattern in which those who receive life from the system often become among its
most steadfast supporters.
3. First
Needle, First Step
Four years
pass. James is eighteen now. The memory of the operating room has softened
around the edges, like an old photograph left in the sun, yet the knowledge of
what saved him has not faded at all. At the same time, his friends talk about
work, cars, football, paychecks, and the following weekend, and something
quieter from the past tugs at him.
A boy in a
hospital bed. A nurse's voice. Bags of blood swinging above him like silent
guardians. One day, he walks into a blood bank. The building is nothing
special: fluorescent lights, vinyl chairs, that faint antiseptic smell that
clings to every clinic and settles in your throat. On the outside, he looks
like any young man running an errand.
On the
inside, his hands feel a little too still, his shoulders overly tight. He is
afraid of needles. That fear never really leaves him. A nurse wraps a
tourniquet around his arm. The rubber bites gently into his skin, and his pulse
flutters beneath her fingers. "First time?" He nods. "We will
look after you. You have this," she says.
The needle
slips in, a sharp sting, then the strange coolness of blood flowing through the
tubing. He watches the bag slowly fill, dark and quiet, like a small night sky
gathered in plastic. Somewhere in the back of his mind, a thought rises, clear
and straightforward. Someone did this for me. Now it is my turn. A circle
begins to close.
He has no
idea that this small act on this unremarkable day is the first line of a larger
story. He walks out with a tiny bandage on his arm and an even smaller sense of
having repaid a debt. The world barely notices. No trumpets sound, no headlines
change. Yet something important has already shifted inside him, like a compass
finding north.
When you
look back over many decades, it is often like this. Turning points do not
announce themselves. They arrive disguised as an ordinary Thursday, a door you
almost did not walk through, a form you almost did not sign, a needle you
almost refused. Quiet moments that, years later, you recognise as the place
where your life quietly changed direction.
James's
first blood donation at eighteen distils a deep truth about altruism. The
moment looks ordinary from the outside, yet it carries the weight of past
vulnerability and future impact. His decision grows from a personal history of
being rescued and becomes his first conscious step into the role of rescuer,
even though he would never use that word about himself.
Research on
first-time blood donors shows that their motivations often reach back to
earlier experiences of illness, loss, or witnessing the suffering of others.
People step into donation centres with a mixture of anxiety and purpose, just
as James did. Fear of needles sits beside a quieter conviction that someone
somewhere will one day need what their arm can offer.
Qualitative
studies describe how the memory of being a patient can shape the choice to
donate. Recipients of transfusion or their relatives frequently speak about a
sense of unfinished conversation with the past, a wish to turn gratitude into
action. That wish, once acted upon, rarely feels grand. Instead, it feels like
an almost private agreement with the self to keep showing up.
The setting
itself, with fluorescent lights and routine procedures, can either soothe or
heighten anxiety. Supportive staff and calm environments help first time donors
like James move through their fear and leave with a sense of quiet achievement.
Many later describe feeling stronger, not because the needle hurt less, but
because they discovered that their fear did not have the final word.
The
evidence also underscores the importance of these early experiences for donor
retention. People who feel respected, heard, and cared for during their first
visit are more likely to return and form the kind of long arc we see in James's
life. One successful experience can turn a tentative step into the beginning of
a lasting habit that, over time, strengthens the blood supply.
Public
health programmes increasingly use personal narratives to invite new donors.
Stories like James's connect the clinical language of "supply" and "demand"
with the real texture of memory, fear, humour, and relief. The ordinary details
of his first visit, his nervousness, and the nurse's reassurance make the
abstract idea of giving blood feel tangible and human rather than distant and
mechanical.
James's
first donation shows how a single act can stand at the meeting point of private
and public worlds. He walks in carrying his own history; he walks out having
added a drop to the shared reservoir that hospitals draw from every day. The
moment is small, yet in that smallness lies the seed of everything his golden
arm would later make possible.
4. The Secret
in His Blood
After he
has donated a few times, the staff ask him to stay behind. "Mr Harrison,"
a doctor says, adjusting his glasses, "there is something unusual about
your blood." James shifts in his chair, half expecting bad news. "Unusual
in a good way," the doctor adds quickly, with a small smile. "Your
plasma has powerful anti-D antibodies."
"It is
rare. We think it could help prevent a disease in newborn babies." They
tell him about Rh disease, how a mother's blood can sometimes attack her unborn
child's blood cells, stripping the red from their tiny bodies and leaving
anemia, brain damage, or death before the baby takes its first breath. At that
time, far too many babies around the world are lost this way.
"We
are developing an injection," the doctor continues. "An anti-D
treatment. Your plasma could be crucial. If you are willing, we would like you
to donate regularly." James blinks. Donating blood had been his way of
settling a personal account with fate, a quiet gesture of repayment for the
strangers who once kept him alive. Now the scale of the request enlarges.
He is being
told that his body might become part of a shield for children he will never
see, for families who will never know his name. He does not ask for a contract.
He does not ask for his name on a plaque. "All right then," he says.
The words are simple, almost casual, yet they mark a turning that no one in the
room can fully see.
If this
were a superhero film, the music would swell, the costume would appear, and the
skyline would glow behind him. James does not get a cape. He gets an
appointment card and a new date to show up. The scene is small, almost
forgettable. Still, in that small room, the world quietly shifts a fraction on
its axis, held by an ordinary man's quiet yes.
The moment
when James learns that his plasma contains rare anti-D antibodies opens a
window into the complex biology of Rh disease and its prevention. His blood
does not only replaces what someone else has lost. It becomes raw material for
a treatment that can stop a mother's immune system from harming her unborn
child, a quiet shield built from another person's immune memory.
Rh disease
arises when an Rh-negative mother carries an Rh-positive fetus. Fetal red cells
crossing into her circulation can trigger an immune response. Her body then
produces antibodies that attack any future Rh-positive pregnancies, with the
potential for severe anemia, heart failure, brain injury, or death. Before
immunoprophylaxis, these pregnancies carried a heavy shadow.
The
development of anti-D immunoglobulin changed this landscape. Administered to Rh-negative
mothers during and after pregnancy, it prevents their immune systems from
forming the damaging antibodies in the first place. Studies show that this
approach has dramatically reduced sensitisation rates and the burden of
hemolytic disease of the newborn in many countries (Miles & Takahashi,
2007; Moise, 2008).
James's
plasma, rich in Anti-D antibodies, belongs to the rare pool needed to produce
this protective treatment at scale. Haas and colleagues describe how Anti-D
preparations have become standard of care for managing Rh incompatibility, with
marked improvements in neonatal outcomes compared with the era before these
injections were available (Haas et al., 2015). Each vial carries the echo of
donors like him.
For mothers
and babies, the effect is felt not in technical language but in quiet rooms
where pregnancy scans bring relief instead of dread. Londero and co-authors
note that the widespread use of Anti-D has helped reduce maternal and neonatal
morbidity and mortality linked to alloimmunisation (Londero et al., 2020).
Behind each improved statistic is a child who comes home instead of staying in
a small hospital graveyard.
When James
agrees to donate regularly, he moves from being a grateful former patient to a
central, though unassuming, contributor to a national prevention programme. His
willingness to keep giving reflects the motivations seen in many donors, who
describe their actions as a way to repay a debt or to stand alongside families
they will never meet (Butler et al., 2023).
Public
health systems rely on donors with rare antibody profiles. Navarro and
colleagues point out that identifying and retaining such donors is essential
for managing specialised transfusion needs and prophylaxis programmes (Navarro
et al., 2010). A single rare donor cannot bear the entire burden, yet each such
person extends what is medically possible for others.
James's
story underlines a quiet contrast. Popular culture often imagines heroism as a
single dramatic act. In reality, his most significant contribution began with a
conversation in a clinic office and grew through repeated, almost routine
appointments. His Anti-D-rich plasma became one of the hidden pillars
supporting safer pregnancies, turning personal resilience into a public good.
5. The Alchemy
of Showing Up
From
eighteen to eighty-one, James Harrison donates plasma 1,173 times, about once
every three weeks for nearly six decades. Each visit takes about an hour. An
hour in a chair. An hour listening to the hum of machines. An hour with the
cool sting of the needle, the faint tiredness as the centrifuge spins and
separates the gold the world needs from the rest.
If you add
those hours together, he spends more than two full months of his life literally
attached to a machine so that other lives can move freely. His family grows
around these appointments. A daughter rolls her eyes at her father's stubborn
schedule. A grandson once asks, "Pop, why do you keep doing this if you
are scared of the needle?"
James
smiles and answers, "Because I remember what it felt like when someone did
it for me." The boy does not yet fully understand, but the answer lodges
somewhere inside him, like a seed waiting for rain. The Anti-D injections made
from James's plasma are given to more than 2 million mothers, helping protect
around 2.4 million babies from Rh disease.
Numbers
like that are hard to feel; imagine them differently. A baby's first cry that
does not turn into an emergency code. A mother who leaves the hospital with her
arms full, not empty. A father who never has to choose a tiny coffin. Now let
those scenes repeat, not once or twice, but millions of times, echoing quietly across
decades and countries.
All of it
ripples outward from one man's decision to keep a promise he made as a boy. Ask
James why he kept going and he only shrugs. "Others helped me when I
needed it," he says. "This is my way of giving back." He never
calls himself a hero. He jokes about being scared of the needle every single
time.
That is the
nature of virtue. We do not become courageous by admiring courage from a
distance. We become courageous by doing the thing that frightens us, again and
again, until it settles into our bones. James becomes generous in human form,
not through grand gestures but through repetition. Consistency is the alchemy
that turns gratitude into gold.
And if you
cannot donate blood because of your health, your age, your body, that does not
shut you out of this story. Your donation may be your time, your listening,
your craft, your patience, your willingness to stand beside someone on a hard
day. The form changes; the thread remains the same, one quiet promise at a
time.
James
Harrison's lifelong pattern of donating plasma, 1,173 times over nearly sixty
years, shows what happens when a private promise hardens into practice. His
single hour in a chair, repeated over thousands of days, becomes a structural
element in a public health system. Each visit looks ordinary. Taken together,
they help reshape outcomes for mothers and babies (Moise, 2008).
Rh disease
once haunted maternity wards, especially where access to prevention was
limited. Rh-negative mothers carrying Rh-positive babies faced repeated risks
of severe anemia and death in their infants (Bhutani et al., 2013). The
implementation of anti-D immunoglobulin shifted this pattern. With timely
injections, clinicians could protect both current and future pregnancies,
turning a recurring tragedy into a manageable risk (Deka et al., 2013).
James's
repeated donations make it possible to sustain such programmes. His story
bridges the gap between policy and practice. On one side, guidelines and supply
targets; on the other, an older man who keeps showing up despite his fear of
needles. Science explains how Rh disease is prevented. His life explains why
the programme can keep running year after year.
The idea
that "consistency is the alchemy that turns gratitude into gold" is
supported by research on blood donor behaviour. Jeong and colleagues describe
how regular donors often link their commitment to a remembered moment of
vulnerability, then reinforce that motivation through habit and identity (Jeong
et al., 2024). Giving becomes part of who they are, not just something they
occasionally do.
Global
progress in reducing Rh-related morbidity depends on both technology and human
reliability. Regions with robust perinatal care and well-organised prophylaxis
programmes report sharp drops in severe hemolytic disease (Irinmwinuwa et al.,
2023). Behind every such programme stand donors, staff, and families who engage
repeatedly, forming a living network that keeps the system from collapsing.
James's way
of turning fear into action offers a broader lesson for public health. Not
everyone can donate blood, yet everyone can participate in patterns that
strengthen community resilience. Hanafi and co-authors highlight how diverse
forms of civic engagement, from volunteering to caregiving, contribute to
collective well-being in ways that mirror the effects of medical donations
(Hanafi et al., 2024). Different gifts, one shared field of care.
His story
widens the definition of contribution. It reminds readers that showing up does
not always feel heroic. Often it feels like an inconvenience, mild discomfort,
or one more appointment squeezed into a busy day. Over time, those small acts
accumulate. For the families whose children are alive because Rh disease was
prevented, that quiet accumulation feels nothing short of miraculous.
6. Pain,
Promise, Pattern
From a
distance, James's life looks like an exception, a headline. The Man Who Saved
Millions. It sounds like something that belongs on a medal or in a museum. Yet
if you walk closer, if you sit with his story the way you sit with an old
friend over a slow cup of tea, another shape emerges. A pattern you start to
recognise everywhere.
Wound,
rescue, gratitude, promise, habit, impact. James is wounded. Anonymous donors
rescue him. He wakes into a life that should have ended and feels a deep, quiet
gratitude that never quite leaves his bones. He makes a promise. He repeats
that promise until it becomes a habit. That habit, carried across years and
decades, ripples outward into an impact he never fully sees.
This
pattern is not his alone. Imagine a young woman who once slept on the streets,
learning to tuck her fear into the lining of her coat at night. One winter, a
shelter takes her in. A volunteer remembers her name, looks her in the eye, and
says, "See you tomorrow," as if her return is something to be
expected. A small sentence, a significant shift.
Years
later, she runs a small café. On Tuesday nights, after closing, she lets
teenagers linger, kids hovering near the same edges she once knew too well. She
serves them coffee, listens to their stories, and shows them how to fill out
job applications and walk into an interview without shrinking. She does not
call it outreach. She just keeps doing it.
Different
details, same pattern. Wound, rescue, gratitude, promise, habit, impact. Alternatively,
think of a boy who almost failed out of school. His exercise books fill with
red marks and sighs. One patient teacher keeps him back after class, day after
day, explaining fractions until the numbers finally stop dancing and settle
into place. The boy discovers that his mind is not broken; it just needed time.
Years
later, that boy becomes a teacher himself, the one who refuses to give up on
struggling children. He stays late. He writes encouragement instead of insults
in red ink. He tells a child, "You are not stupid. You just have not found
your way in yet." Some of his students grow into doctors, artists,
mechanics, and gentle parents who choose not to repeat old violence.
When we
learn to see this pattern, the world tilts slightly. We stop dividing people
into heroes and ordinary. We begin to suspect that many of the quietest lives
around us are, in fact, long, slow miracles in disguise. The neighbour who
keeps checking on an elderly friend. The nurse who stays five minutes longer in
a room that smells of fear.
The uncle
who shows up at every game for a child that is not his. None of them will ever
be introduced as The One Who Saved Millions, yet in small radiating circles,
they are doing precisely that. And then the more uncomfortable questions
arrive, tapping gently. Where is this pattern hiding in my own life. What wound
did I survive. Who rescued me.
What
promise did I once whisper, then forget. Perhaps you, too, are already halfway
through a story of quiet glory. You just have not given it a name yet. With
age, you start to realise that the stories you admire and the story you are
living may be closer than you thought. Different clothes, different streets,
yet the same hidden pattern.
A hurt that
did not have the final word. A kindness that refused to disappear. A promise,
kept long enough, that it began to change more than one life. Once you see that
pattern, you begin to see yourself not only as a character in your own story,
but as a thread in a much larger tapestry still being woven.
James
Harrison's journey, from gravely ill teenager to committed plasma donor, fits a
narrative arc that many people recognise at a deeper level. Wound, rescue,
gratitude, promise, habit, impact. This sequence describes his life, yet it
also echoes in many other stories in which pain does not end a life but becomes
the soil for later generosity (Bove et al., 2011).
His wound,
the surgery, and the transfusions that saved him created an opening for
gratitude that did not fade. That gratitude led to a promise to give back when
he could. The promise then became a habit, 1,173 donations over decades. The
impact extended beyond his imagination, as his anti-D-rich plasma helped
protect babies from Rh disease across generations (Bove et al., 2011).
Studies on
adversity and prosocial behaviour support this pattern. Thorpe and colleagues
note that people who have faced hardship often become strongly motivated to
support others, especially in contexts similar to their own experiences (Thorpe
et al., 2019). A child once helped out of danger grows into an adult who
quietly waits at the same crossroads for someone else.
Research on
blood donors shows that emotional memories play a crucial role. Bryant and co-authors
describe how those who have received donations, or have seen loved ones receive
them, often feel a deep sense of obligation mixed with gratitude (Bryant et
al., 2023). This feeling can blossom into repeated donations, transforming a
single rescue into a long-term resource for many others.
Tran Mi and
colleagues highlight how strong community ties and shared narratives support
donor retention (Tran Mi et al., 2004). When people see their giving as part of
a larger story, they are more likely to maintain the habit. James's story can
be read as one such narrative, making visible how a private vow becomes a
public good.
Generosity
rarely stays contained. Covington and co-authors outline how acts of kindness
can ripple through families and communities, inspiring others to step into
similar roles (Covington et al., 2023). A once-struggling student becomes a
patient teacher. A former shelter resident becomes a safe adult for the next
generation. The pattern repeats with new actors, yet familiar rhythms.
James's
life invites readers to consider their own place in this pattern. Which wounds
still ache, yet might one day feed empathy. Which rescues still echo, asking to
be honoured in some form of giving. Naming this pattern does not turn every
hardship into a tidy lesson. It simply reminds us that pain can be a starting
point, not only an ending.
- Giving Words to Quiet
Souls
James
Harrison was not a philosopher or a polished speaker. He was a railway man, a
husband, a father, a grandfather. He worried about needles, made small talk
with nurses, and went home to an ordinary house. When reporters later asked him
about his golden arm, he never turned it into a grand story. He just shrugged,
as if all the fuss were about someone else.
"Others
helped me," he said. "This is my way of giving back." That was
his whole speech. No theory, no slogan, just a simple sentence tested quietly
for decades. Epictetus once said that it is not what happens to us, but how we
respond, that defines us. James never quoted that line. Some people live
philosophy more clearly than those who write it.
His
response to his own suffering was not bitterness, not drama, but a promise
repeated in the same vinyl chair again and again, until the promise became part
of who he was. Our task, as friends, family, and fellow travellers moving
beside such people, is sometimes to become translators of goodness. We put
language to what their lives have been quietly saying.
We take
actions that look small from the outside and give them words that reveal their
true size, so that the one who acted can finally see what they have done. To
James, we might say, if he would let us, "You did not just donate blood.
You donated birthdays, first days of school, awkward teenage years, wedding
days, lazy Sunday mornings."
To the
former homeless barista, we might say, "You are not just making coffee.
You are warming the nights of young people standing where you once stood,
teaching their hearts a different ending." To the quiet teacher, bent over
stacks of exercise books, we might say, "You are not just grading papers.
You are editing the story your students tell themselves about their worth."
This is not
flattery. It is respect, the kind of respect that looks closely enough to trace
the full outline of a life. Helping someone find words for their goodness is
itself an act of goodness. And if you live long enough, you learn this: most
people are carrying more light than they know. They move through their days
thinking they are ordinary.
In fact,
they have been holding up a corner of the sky for years. Sometimes all they
need is for someone to say, very simply, "Do you realise what that meant
to me." In that moment, the scattered pieces of their story come together.
Their own life finally makes a quiet kind of sense to them, as if a blurred
image has come into focus.
Rh disease
once carried high risks of hemolytic anemia, jaundice, and death in newborns
born to Rh-negative mothers with Rh-positive babies. Anti-D immunoglobulin,
derived from plasma rich in Anti-D antibodies, changed this prognosis. Routine
administration to at-risk mothers brought steep drops in morbidity and
mortality associated with this condition (Barlow, 2005; Thorpe et al., 2022).
Harrison's
repeated donations made him a key source for producing this immunoglobulin.
While the programme draws on many donors, its rare antibodies and long record
of participation gave clinicians a degree of reliability that is hard to
measure in numbers alone. Each successful pregnancy that would once have ended
in tragedy carries a trace of his quiet persistence.
His public
persona, modest and slightly uncomfortable with praise, highlights something
important about altruism. Barlow points out that long-term donors often see
their contributions as simply doing their part, even when the wider system
depends heavily on their consistency (Barlow, 2005). Harrison's shrugging
acceptance of attention masks a depth of commitment that many public figures
never reach.
The symbol
of the golden arm invites reflection. It refers not only to the biological
rarity of his antibodies, but also to the enduring quality of his generosity.
Gold keeps its shape under pressure. His steady participation in the donation
programme mirrors that resilience. Over time, his arm became a kind of quiet
infrastructure, as essential as any physical building.
Research on
donor recognition shows that telling stories like his can encourage others to
donate and stay engaged. Schroyens and colleagues note that thoughtful
acknowledgment of donors, without flattery or pressure, helps build trust and
long-term relationships with blood services (Schroyens et al., 2023). Harrison's
story serves as a bridge between abstract need and personal meaning.
Schulzki
and co-authors emphasise that strong plasma programmes require both sound
logistics and a culture that values giving (Schulzki et al., 2006). The
narrative of The Man with the Golden Arm contributes to that culture. It
reminds health professionals and the public that behind each vial of Anti-D
stand real people, with fears and families, who chose to keep showing up.
9. The Last
Donation
In 2018,
new guidelines required blood donors to stop at eighty-one. James has reached
that age. On an ordinary day that is not ordinary at all, he walks into the
donation centre one final time. The staff know what this visit means. Some grew
up in a world already shaped by the Anti-D programme; they have heard his name
since medical school.
Now the
legend is just an older man in a familiar shirt, hanging up his coat, moving more
carefully than he used to. A few of them feel their throats tighten as they
watch him sign in. He climbs into the same chair he has known for decades. The
vinyl has changed, the posters on the walls have been updated.
The ritual
is the same. A nurse who has seen him dozens of times wraps the tourniquet
around his arm with a tenderness that belongs more to family than to protocol. "Ready,
James?" "As I will ever be," he grins. "Still do not like
needles, you know." She laughs. "After all these years?" "Never
liked them," he says. "Just liked the reason."
The needle
goes in. The machine begins its gentle hum. For an hour, it looks like any
other hour. Tubes, beeps, quiet conversation. Everyone in the room feels the
difference. This hour contains all the others, like tree rings hidden in a
trunk. When the needle is removed and a cotton pad taped to his arm, something
breaks loose.
A small
round of applause rises, hesitant at first, then warm. A staff member steps
closer and says softly, "You know, James, there are millions of people who
owe you their lives." He waves it away, embarrassed, as if someone has
mistaken him for someone important. "Come on. It is a team effort. I just
did my bit." He means it.
He steps
out into the daylight. He is eighty-one now, a little slower on his feet, his
joints speaking in the quiet language of age. Inwardly, something feels very
still and very clear, as if a long sentence he began writing as a boy has
finally reached its full stop. The line of his promise closes, yet the echo
keeps travelling.
If
Nietzsche's question were put to him, Would you live it all again, the same,
you can almost hear the answer. Of course. Needles, fear, hospital memories and
all. When I picture him walking out into that light, I also picture older faces
I have known, lined not only by pain but by promises kept. There is a
particular calm there.
It belongs
to people who have quietly done what they said they would do, even when no one
was watching. It is not the calm of having avoided suffering, but the peace of
having turned suffering into a vow, then kept that vow, one small appointment
at a time. A calm that whispers to anyone listening, You can live like this
too.
James
Harrison's final donation at eighty-one marks the end of a singular personal
journey and a chapter of transfusion history. His last visit takes place under
new age-based guidelines, yet it carries the weight of decades of consistent
giving that helped anchor the Anti-D programme and reshaped outcomes for Rh-negative
mothers and their babies (Wagner et al., 2005).
The anti-D
immunoglobulin that his plasma helped supply had already transformed RhD
hemolytic disease from a frequent cause of fetal and neonatal death into a
condition that clinicians could often prevent or manage. Wagner and colleagues
describe how the availability of such immunoglobulin changed obstetric
practice, turning many once fatal pregnancies into safe deliveries (Wagner et
al., 2005). James's long record of donations supported this shift.
During his
final visit, the staff's emotional response reflects more than admiration for
an individual. They are responding to what he represents. A living link between
early, fragile trials of Anti-D prophylaxis and the confident routine practice
they now teach to new generations. His presence ties their everyday work to its
deeper roots.
His
comment, "Never liked needles. Just liked the reason," captures the
spirit of genuine altruism. He did not donate because he enjoyed the process.
He donated because he remembered being on the other end of the tube. Greenough
and colleagues highlight that such memory-based motivations often underlie long
term volunteer involvement in health-related programmes (Greenough et al.,
2002).
Harrison's
story underscores the importance of recognising donors not only as suppliers,
but as partners in public health. His life gives a human narrative to
statistical claims that Anti D prophylaxis has saved many lives. For future
donors and staff, that narrative can serve as both encouragement and a reminder
of why their work matters.
As he
leaves the centre that day, carrying a sense of completion, the programme
continues without him. Younger donors step into the chairs he once occupied.
The system has been designed to survive the ending of any single thread. Yet
the memory of his contribution remains part of its culture, a quiet benchmark
for what sustained commitment can look like.
His final
walk into the light invites reflection for anyone who has ever made a promise
in response to pain. It suggests that a life shaped by such promises can reach
old age with a particular kind of peace. Not the peace of having escaped
struggle, but the stillness of knowing that what once almost broke you has
become a gift you have placed in other hands.
10. When a
Golden Thread Ends
On March 2,
2025, at eighty-eight years old, James Harrison dies peacefully in a nursing
home on Australia's Central Coast. No cameras wait outside. No fanfare marks
the exact moment his heart grows quiet. A nurse notes the time. A family member
wipes their eyes. For a brief instant, the world seems unchanged. The quiet man
is gone.
Then the
noise arrives. News outlets around the world begin to share his story. The Man
with the Golden Arm Has Died. Headlines travel across countries and languages.
Social media fills with tributes and photographs, an older man with kind eyes,
a familiar bandage on the crook of his arm. The world that did not notice each
appointment now notices the sum.
Doctors
write about how his donations made their work possible, how the Anti D
programme they now take for granted was once a fragile hope that his blood
helped anchor. Nurses remember his terrible jokes, his fear of needles, and the
way he always tried to make them feel at ease. Their memories sketch a portrait
more tender than any medal.
Woven among
their words are messages from parents. One mother writes, "To the man I
never met: an Anti-D injection made from your plasma was given to me in 2012.
My son turned twelve this year. He plays the drums too loudly and leaves his
socks everywhere. He is alive because of you. Wherever you are now, thank you."
It is just
one voice among thousands, a single thread in a tapestry too large for any one
person to see. If James could read it, if he could sit in a quiet corner with a
cup of tea and scroll through all those messages, he might finally glimpse what
his quiet habit became. Not just bags of plasma and charts.
Birthday
candles. Off key songs. Scraped knees. Teenage arguments. First loves. Ordinary
days that only exist because he kept turning up. His life whispers something
simple. Your gratitude can become someone else's survival if you let it travel
from feeling to commitment. Whether he meant to or not, he leaves behind that
message in every vein his blood once reached.
It is
braided through every appointment card, every needle, every smile for a nervous
first-time donor. A promise, kept quietly over time, can grow larger than the
person who made it. Sometimes the softest life leaves the loudest echo. If you
listen closely, that echo does not only praise him. It asks quietly, "What
will you do with your own thread?"
James
Harrison's death on March 2, 2025 closes a remarkable life story and invites
reflection on the scale of his impact. As The Man with the Golden Arm, he
contributed to the development and stability of the Anti-D immunoglobulin
programme, which has dramatically reduced the incidence of hemolytic disease of
the newborn. His passing highlights how much modern obstetric care has come to
rely on such programmes (Thyer et al., 2018).
The legacy
he leaves is not only clinical. The flood of tributes from parents, clinicians,
and members of the public shows how deeply an individual can touch lives
through steady commitment. Thyer and colleagues describe how structured
prophylaxis programmes depend on both scientific advances and sustained donor
engagement (Thyer et al., 2018). Harrison's long series of donations became one
of the hidden supports of that engagement.
Parents
writing about children who would not be alive without anti-D injections turn
abstract outcomes into human stories. These stories echo findings that personal
narratives can strengthen public support for health initiatives and encourage
participation in donation, volunteering, or advocacy (Thorpe et al., 2022). People
are moved less by numbers than by images of children playing drums too loudly.
His death
also reminds blood services of the importance of recruiting and retaining new
donors to continue the work he helped sustain. Appeals that connect present
donors to past figures like Harrison can help create a sense of continuity and
purpose. Programmes that honour past contributors while inviting fresh
participation may be better placed to meet ongoing and future needs.
For health
professionals, his story underscores the value of acknowledging the people
whose contributions make their daily practice possible. Recognising donors as
partners in care can build a culture of gratitude that flows both ways, from
staff to donors and from donors back to staff. This mutual respect can support
resilience in systems that often operate under strain.
Looking
back on James Harrison's golden thread, we see more than one man's generosity.
We see a vivid illustration of how gratitude, when turned into long-term
action, can alter the landscape for generations. His life invites each reader
to imagine what might happen if their own small gratitude, whatever its source,
were also given room to grow into a habit.
11. Your Golden
Thread
Now the
glow of this story turns gently toward you. If it feels safe enough, close your
eyes for a moment and let your own life rise to the surface. Was there a time
when your world almost went over the edge but did not. A night when everything
felt lost until someone showed up, a doctor, a stranger, a teacher, a friend, a
neighbour.
Was there a
season when you thought, I will never forget this. One day I will give back,
and then life moves on, as it always does, and that promise sank beneath the
noise of ordinary days. Maybe you have already begun to keep it without
realising. Maybe you are raising a child with more tenderness than you ever
received.
Maybe you
send a small monthly gift to the organisation that once held you up when you
were falling. Maybe you answer late-night messages because you remember what it
felt like to be awake at three in the morning, convinced that no one cared.
These things may feel small, almost embarrassing to mention beside a story like
James's.
They are
not small. Every quiet act, repeated over time, becomes part of the
architecture of someone else's life, a beam, a doorway, a light left on in a
dark room. What if your smallest habit is the universe's way of rewriting fate
for someone you will never meet. What if your golden arm is not in your veins
at all.
It may live
in your listening, your patience, your courage, your craft, your willingness to
show up once more when it would be easier to look away. Learn to see patterns
like James's in the lives around you, the same arc of wound, rescue, gratitude,
promise, habit, impact playing out in different clothes and different streets.
Notice where it touches you.
Learn to
give people the words they cannot yet say about themselves, so they can finally
recognise the goodness they already carry. And learn, slowly and without hurry,
to let your own life become a message, not through speeches or slogans, but
through one promise kept over time. One day, you may look back and see it
clearly.
Your quiet
thread, too, has been woven into the fabric of someone else's survival. Not
perfectly. Not without regret. Just honestly, one small choice at a time. The
question waiting at the edge of this chapter is unsettling and straightforward.
If you were to name your promise now, even in a single line, what might it be
willing to become?
Reflecting
on one's personal journey can bring unexpected clarity about how deeply our
lives are intertwined. The invitation to remember moments when someone showed
up for us is not a sentimental decoration. It is a way of tracing how rescue,
gratitude, and promise may already be shaping how we live our days, often
without our full awareness (Marteau, 2025).
Many people
discover that their current habits quietly honour past help. Raising a child
with more gentleness than one received, supporting an organisation that once
offered refuge, or staying awake with a friend in distress can all be ways of
paying forward earlier care. These acts may appear modest, yet they often serve
as crucial supports in others' lives.
Research
suggests that small but regular acts of kindness can have powerful effects on
emotional and psychological well-being, both for those who give and for those
who receive ("AFP stresses need for donor retention, engagement in State
of the Sector report", 2015). In practice, this might look like a
consistent volunteer, a steady donor, or a reliable listener whose presence
keeps others from falling through the cracks.
The pattern
seen in James's life, wound, rescue, gratitude, promise, habit, and impact, can
serve as a lens to understand our own trajectories. Kazanskaia notes that
recognising such patterns helps people connect their private histories with
broader social narratives, giving meaning to experiences that once felt
isolated (Kazanskaia, 2025). Personal identity becomes a message, not only a
memory.
As we learn
to name the goodness we see in ourselves and others, we create language that
supports further action. Annual impact reports and similar tools can help
organisations communicate this, yet the same principle can apply in daily life
("Teaching Paper: Annual Impact Reports – A Strategic Template for
Nonprofit Accountability and Communication", 2025). Telling someone,
"What you did changed me," can be its own kind of report.
James's
story shows one path, centred on blood donation and medical impact. Your path
may look very different. The underlying lesson remains. Gratitude does not have
to stay as a feeling. It can harden into a promise and then soften again into
habit, shaping the lives around you. The golden thread you carry might be
waiting for a name and a next step.
12. The Story
We Write Together
We share
this story in a digital age, with screens glowing where firelight once
flickered. The oldest questions have not changed. What does it mean to live
well? How do we carry our suffering without letting it turn us bitter. How do
we honour the ones who kept us alive when we might have been lost. How do we
leave the world kinder.
James
Harrison's answer was disarmingly simple. Show up. Keep your promise. Let your
gratitude harden into habit. Aristotle might have called that virtue. Frankl
might have called it meaning. Ubuntu might have called it being human together.
James did not quote any of them. He just rolled up his sleeve and did the thing
he had decided to do.
So if
anyone ever asks, "Where are the heroes now," you do not have to
point to capes or speeches or monuments. You can answer quietly, almost to
yourself. Some of them are simply people who kept a promise. And if you choose,
one of them can be you. Not perfect, not famous, just steady in the direction of
your vow.
If you are
reading this on a screen, you can turn it into a small ritual. Nothing grand,
just a seed you plant in the soil of your own life. Write one line somewhere,
in a notebook, on a scrap of paper, in the notes on your phone. This is the
promise I will keep. It does not have to be dramatic.
It does not
have to impress anyone. It just has to be real. The story of James Harrison has
reached its final chapter. His thread has run its length. The story of us,
humans helping humans, weaving golden strands through one another's days, is
still being written line by quiet line, in ordinary hands and aging hearts like
yours and mine.
Somewhere,
years from now, a child may laugh in a kitchen you will never see, not knowing
that, far away in another time, you once decided to show up, and that decision
became part of the story we are all writing together. That possibility does not
demand heroics. It asks for something stranger and harder, faith in the power
of small kept promises.
The
narrative of James Harrison and the reflections that surround his life draw
together themes of altruism, public health, and shared meaning. His story
stands as a case study in how one person's choices can interact with scientific
advances to change outcomes on a broad scale, while remaining rooted in
ordinary routines and fears.
Scholarly
work on blood donation, donor motivation, and community engagement gives
language to patterns visible in his life. It explores how gratitude becomes a
repeated action, how programmes like Anti-D prophylaxis depend on both
technology and trust, and how stories can help maintain that trust. Yet his
example keeps these themes grounded in human detail rather than abstract
theory.
Taken
together, the chapters of his life invite readers to do more than admire a
remarkable man. They encourage us to see our own experiences of wound, rescue,
gratitude, promise, habit, and impact. The scientific references offer one kind
of map. The memories we carry, and the promises we choose to keep, offer
another. Both maps matter for the story we write together.
References
Gillespie, E. R., & Ruitenberg, M.
J. (2022). Neuroinflammation after SCI: Current Insights and Therapeutic
Potential of Intravenous Immunoglobulin. Journal of Neurotrauma, 39(03-Apr),
320-332. https://doi.org/10.1089/neu.2019.6952
Triolo, G., Ferrante, A.,
Accardo-Palumbo, A., Ciccia, F., Cadelo, M., Castelli, F., Perino, A., &
Licata, G. (2004). IVIG in APS pregnancy. Lupus, 13(9), 731-735.
https://doi.org/10.1191/0961203304lu2011oa
Maheshwari, A., Varshney, M., Bajpai,
M., Raizada, N., & Sharma, T. (2022). An Exploratory Study of the
Differences in Attitudes and Motives Regarding COVID-19 Plasma Donation. Acta
Medica Lituanica, 29(1), 69-77. https://doi.org/10.15388/amed.2022.29.1.14
Ben‐Nathan,
D., Gershoni‐Yahalom,
O., Samina, I., Khinich, Y., Nur, I., Laub, O., Gottreich, A., Simanov, M.,
Porgador, A., Rager‐Zisman,
B., & Orr, N. (2009). Using high-titer West Nile intravenous immunoglobulin
from selected Israeli donors for treatment of West Nile virus infection. BMC
Infectious Diseases, 9(1). https://doi.org/10.1186/1471-2334-9-18
Montoliu‐Gaya, L., & Villegas, S. (2016).
A<i>β</i>-Immunotherapeutic strategies: a wide range of approaches
for Alzheimer's disease treatment. Expert Reviews in Molecular Medicine, 18.
https://doi.org/10.1017/erm.2016.11
Gharebaghi, N., Nejadrahim, R., Mousavi,
S. J., Sadat‐Ebrahimi,
S., & Hajizadeh, R. (2020). The use of intravenous immunoglobulin gamma for
the treatment of severe coronavirus disease 2019: A randomised
placebo-controlled double-blind clinical trial.
https://doi.org/10.21203/rs.3.rs-40899/v2
Xiao, Y., Xu, H., Guo, W., Zhao, Y.,
Luo, Y., Wang, M., He, Z., Ding, Z., Liu, J., Deng, L., Sha, F., & Ma, X.
(2020). Update on treatment and preventive interventions against COVID-19: an
overview of potential pharmacological agents and vaccines. Molecular
Biomedicine, 1(1). https://doi.org/10.1186/s43556-020-00017-w
Rajan, A., & Narayanan, D. (2023).
COVID-19 Convalescent Plasma Collection: A Cross-Sectional Study From the
Perspective of Transfusion Medicine. National Journal of Laboratory Medicine,.
https://doi.org/10.7860/njlm/2023/59648.2721
Wang, B., Higgins, M., Kleinman, S.,
Schreiber, G. B., Murphy, E. L., Glynn, S. A., Wright, D. J., Nass, C. C.,
Chang, D., Busch, M. P., & Study, F. T. R. E. D. (2004). Comparison of
demographic and donation profiles and transfusion‐transmissible disease markers and risk
rates in previously transfused and nontransfused blood donors. Transfusion,
44(8), 1243-1251. https://doi.org/10.1111/j.1537-2995.2004.04034.x
Gahan, L., Masser, B. M., Mwangi, C.,
Thorpe, R., & Davison, T. E. (2021). Motivators, facilitators, and barriers
to blood donation in Australia by people from ethnic minority groups:
Perspectives of sub-Saharan African, East/South-East Asian, and Melanesian/Polynesian
blood donors. Journal of Sociology, 58(1), 95-112.
https://doi.org/10.1177/1440783321999462
Akhtar, B. S., Sultana, N., Farzana, S.,
Ahmed, R., & Rubby, M. G. (2017). Awareness about blood donation among
donors at a specialized tertiary level public hospital.. Update Dental College
Journal, 6(2), 21-26. https://doi.org/10.3329/updcj.v6i2.31724
Gupta, S., Madan, A., Dhar, R., &
D.B., B. (2013). A RETROSPECTIVE STUDY OF ADVERSE EVENTS IN BLOOD DONORS FROM
NAVI MUMBAI.. Journal of Evolution of Medical and Dental Sciences, 2(11),
1575-1580. https://doi.org/10.14260/jemds/427
Cable, R. G., Musavi, F., Notari, E. P.,
& Zou, S. (2007). Limited effectiveness of donor deferral registries for
transfusion‐transmitted
disease markers. Transfusion, 48(1), 34-42.
https://doi.org/10.1111/j.1537-2995.2007.01480.x
Eder, A. F., Herron, R., Strupp, A., Dy,
B. A., Notari, E. P., Chambers, L. A., Dodd, R. Y., & Benjamin, R. J.
(2007). Transfusion‐related
acute lung injury surveillance (2003‐2005)
and the potential impact of the selective use of plasma from male donors in the
American Red Cross. Transfusion, 47(4), 599-607.
https://doi.org/10.1111/j.1537-2995.2007.01102.x
Vasudev, R., Sawhney, V., Dogra, M.,
& Raina, T. (2016). Transfusion-related adverse reactions: From
institutional hemovigilance effort to National Hemovigilance program. Asian
Journal of Transfusion Science, 10(1), 31. https://doi.org/10.4103/0973-6247.175391
Miles, J. H., & Takahashi, T.
(2007). Lack of association between Rh status, Rh immune globulin in pregnancy
and autism. American Journal of Medical Genetics Part A, 143A(13), 1397-1407.
https://doi.org/10.1002/ajmg.a.31846
Moise, K. J. (2008). Management of
Rhesus Alloimmunization in Pregnancy. Obstetrics and Gynecology, 112(1),
164-176. https://doi.org/10.1097/aog.0b013e31817d453c
Haas, M. D., Thurik, F. F., Koelewijn,
J. M., & Schoot, C. E. V. D. (2015). Haemolytic disease of the fetus and
newborn. Vox Sanguinis, 109(2), 99-113. https://doi.org/10.1111/vox.12265
Londero, D., Monge, J., & Hellberg,
Å. (2020). A multi‐centre
study on the performance of the molecular genotyping platform ID RHD XT for
resolving serological weak RhD phenotype in routine clinical practice. Vox
Sanguinis, 115(3), 241-248. https://doi.org/10.1111/vox.12886
Butler, E. A., Parikh, R., Grandi, S.
M., Ray, J. G., & Cohen, E. (2023). ABO and Rh blood groups and risk of
infection: systematic review and meta-analysis. BMC Infectious Diseases, 23(1).
https://doi.org/10.1186/s12879-023-08792-x
Navarro, M., Negre, S., Golombek, S.,
Matoses, M. L., & Vento, M. (2010). Intravenous Immune Globulin: Clinical
Applications in the Newborn. Neoreviews, 11(7), e370-e378.
https://doi.org/10.1542/neo.11-7-e370
Moise, K. J. (2008). Management of
Rhesus Alloimmunization in Pregnancy. Obstetrics and Gynecology, 112(1),
164-176. https://doi.org/10.1097/aog.0b013e31817d453c
Bhutani, V. K., Zipursky, A., Blencowe,
H., Khanna, R., Sgro, M., Ebbesen, F., Bell, J., Mori, R., Slusher, T. M.,
Fahmy, N., Paul, V. K., Du, L., Okolo, A., Almeida, M. F. B. D., Olusanya, B.
O., Kumar, P., Cousens, S., & Lawn, J. E. (2013). Neonatal
hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment
estimates for 2010 at regional and global levels. Pediatric Research, 74(S1),
86-100. https://doi.org/10.1038/pr.2013.208
Deka, D., Sharma, A., Dadhwal, V.,
Singh, A., Kumar, G., & Vanamail, P. V. (2013). Direct Fetal Intravenous
Immunoglobulin Infusion as an Adjunct to Intrauterine Fetal Blood Transfusion
in Rhesus-Allommunized Pregnancies: A Pilot Study. Fetal Diagnosis and Therapy,
34(3), 146-151. https://doi.org/10.1159/000353236
Jeong, I. H., Yu, S., Kim, T. Y., Oh,
S., & Cho, D. (2024). Guide to Rho(D) Immune Globulin in Women With
Molecularly Defined Asian-type DEL (c.1227G>A). Annals of Laboratory
Medicine, 44(4), 307-313. https://doi.org/10.3343/alm.2023.0356
Irinmwinuwa, E. O., Mbah, C. A., Oyate,
G. B., Festa, O. C., & John-Iganga, A. A. (2023). Effect of Rhesus factor
incompatibility on maternal outcome (fertility): A comprehensive review.
International Journal of Frontiers in Life Science Research, 5(2), 001-007.
https://doi.org/10.53294/ijflsr.2023.5.2.0081
Hanafi, R., Zulkeflee, R. H., Hassan, M.
N., Saidin, N. I. S., Adzahar, S., & Hassan, R. (2024). Anti-D
Alloimmunization Following Rhesus-Incompatible Platelet Transfusion in a
Myelodysplastic Syndrome Patient. Cureus,. https://doi.org/10.7759/cureus.57165
Bove, L. L., Bednall, T. C., Masser, B.
M., & Buzza, M. (2011). Understanding the plasmapheresis donor in a
voluntary, nonremunerated environment. Transfusion, 51(11), 2411-2424.
https://doi.org/10.1111/j.1537-2995.2011.03168.x
Thorpe, R., Masser, B. M., Nguyen, L.,
& Davison, T. E. (2019). Understanding donation frequency: insights from
current plasma donors. Vox Sanguinis, 115(2), 174-181.
https://doi.org/10.1111/vox.12861
Bryant, J. A., Woolley, T., Gupta, T.
S., & Chell, K. (2023). Using competition for plasma donor recruitment and
retention: An Australian university case study. Vox Sanguinis, 119(2), 155-165.
https://doi.org/10.1111/vox.13582
Tran‐Mi, B., Storch, H., Seidel, K.,
Schulzki, T., Haubelt, H., Anders, C. J., Nagel, D., Siegler, K. E., Vogt, A.,
Seiler, D., & Hellstern, P. (2004). The impact of different intensities of
regular donor plasmapheresis on humoral and cellular immunity, red cell and
iron metabolism, and cardiovascular risk markers. Vox Sanguinis, 86(3),
189-197. https://doi.org/10.1111/j.0042-9007.2004.00408.x
Covington, M. L., Voma, C., &
Stowell, S. R. (2023). The impact of the <scp>COVID</scp>‐19 pandemic on source plasma donations.
Journal of Clinical Apheresis, 38(5), 644-646.
https://doi.org/10.1002/jca.22083
Barlow, R. (2005). Bravo! The Rh Project
Donor. Transfusion Medicine, 15(1), 69-82.
https://doi.org/10.1111/j.1365-3148.2005.00554ae.x
Thorpe, R., Kruse, S. P., & Masser,
B. M. (2022). It is about who you know (and how you help them): Insights from
staff and donors about how to recruit and retain a panel of committed
<scp>anti‐D</scp>
donors. Vox Sanguinis, 117(5), 664-670. https://doi.org/10.1111/vox.13242
Schroyens, N., D’aes, T., Buck, E. D.,
Mikkelsen, S., Tiberghien, P., Hurk, K. V. D., Erikstrup, C., Compernolle, V.,
& Remoortel, H. V. (2023). Safety and protection of plasma donors: A
scoping review and evidence gap map. Vox Sanguinis, 119(2), 110-120.
https://doi.org/10.1111/vox.13544
Schulzki, T., Seidel, K., Storch, H.,
Karges, H. E., Kießig, S., Schneider, S., Taborski, U., Wolter, K., Steppat,
D., Behm, E. C., Zeisner, M., & Hellstern, P. (2006). A prospective
multicentre study on the safety of long‐term
intensive plasmapheresis in donors (SIPLA). Vox Sanguinis, 91(2), 162-173.
https://doi.org/10.1111/j.1423-0410.2006.00794.x
Wagner, T., Körmöczi, G. F., Buchta, C.,
Vadon, M., Lanzer, G., Mayr, W. R., & Legler, T. J. (2005). Anti‐D immunization by DEL red blood cells.
Transfusion, 45(4), 520-526. https://doi.org/10.1111/j.0041-1132.2005.04256.x
Greenough, A., Hartnoll, G., Hambley,
H., & Richards, J. T. (2002). Treatment requirements of infants with rhesus
isoimmunisation within a geographically defined area. Archives of Disease in
Childhood - Fetal and Neonatal Edition, 87(3), 202F-203. https://doi.org/10.1136/fn.87.3.f202
Thyer, J., Wong, J., Thomson, A., Bell,
B., Hyland, C. A., & Challis, D. (2018). Fifty years of RhD immunoglobulin
(anti‐D) therapy
in Australia: celebrating a public health success story. The Medical Journal of
Australia, 209(8), 336-339. https://doi.org/10.5694/mja17.01144
Thorpe, R., Kruse, S. P., & Masser,
B. M. (2022). It is about who you know (and how you help them): Insights from
staff and donors about how to recruit and retain a panel of committed
<scp>anti‐D</scp>
donors. Vox Sanguinis, 117(5), 664-670. https://doi.org/10.1111/vox.13242
Marteau, É. (2025). The power of
micro-campaigns in an annual giving programme. 10(2), 151.
https://doi.org/10.69554/kevq1696
(2015). AFP stresses need for donor
retention, engagement in State of the Sector report. Nonprofit Business
Advisor, 2016(316), 06-Jun. https://doi.org/10.1002/nba.30146
(2025). Teaching Paper: Resource
Mobilization Tools for Sustainable Nonprofit Growth – Practical Technologies
for Donor Management, Grants, and Community Engagement.
https://doi.org/10.64357/neya-gjnps-str-sus-grth-tp-03
Kazanskaia, A. N. (2025). Measuring
Success and Impact in Major Donor Cultivation.
https://doi.org/10.64357/neya-gjnps-dn-cl-gft-10
(2025). Teaching Paper: Annual Impact
Reports – A Strategic Template for Nonprofit Accountability and Communication.
https://doi.org/10.64357/neya-gjnps-vmda-tp-05